Sharing the latest in health, science, and current events. Pro-vaccine, fact-driven, and here to highlight what matters. 💉🌍 #PublicHealth #ScienceNews

Joined July 2015
Analysts' Analyst retweeted
LAST CHANCE to be included in this year's selections to present your company in-person and/or virtually to potential investors and partners at #BiotechShowcase or its specialized Showcases. Click here to apply >> spr.ly/60173yfoH
1
75
Analysts' Analyst retweeted
Are you a Digital #Therapeutic and #Medtech or an #AI and Machine Learning Company? Our investors are looking for #innovators like you to take to the next level. Grasp your opportunity today and apply to present >> spr.ly/60153DXPB #BiotechShowcase
3
1
Analysts' Analyst retweeted
ABL and RD-Biotech to partner on cell and gene therapy manufacturing buff.ly/3W7oHfa
1
1
Analysts' Analyst retweeted
Medi-Ops is develpoing a cloud-based platform for healthcare organizations to schedule transportation for therapeutics, optimizing for speed and cost. buff.ly/2HTba69 #Biofuture2022 #medtech #machinelearning #AI #therapy @demycolton
2
1
Analysts' Analyst retweeted
Zavain Dar, Co-Founder and Managing Partner at Dimension will be at the #BioHiveSummit for his presentation, “Investing in Healthcare Technologies of the Future.” Register now: bit.ly/3eQjfwi
Analysts' Analyst retweeted
For millions of immunocompromised people, COVID-19 is far from over. Current vaccines aren't offering enough protection to this vulnerable population. nationalgeographic.com/scien… #COVID-19 #variants #vaccines #immunocompromised @NatGeo
Analysts' Analyst retweeted
Two Vaccine Targets on Virus May Be Better Than One: GeoVax's GEO-CM04S1 induces immune responses that target the spike protein and "nucleocapsid," or shell, of the virus. medscape.com/viewarticle/970… #COVID-19 #vaccine #spikeprotein #immuneresponses #TCells @Medscape @Reuters $GOVX
Analysts' Analyst retweeted
Organic Pipeline Expansion in the CNS/Rare Disease indications kempharm-1.reportablenews.co… #prodrugs #CNS #raredisease #pipeline #expansion $KMPH
Analysts' Analyst retweeted
Developing a Full Suite of B2B Business Solutions for the Cannabis Industry buff.ly/2j1reJd $MSRT #smallcap @MassRoots @irthcomm
3
1
Reading the Leaves for the Future of WeedTech buff.ly/2wj059y $MSRT #cannabis #smallcap @MassRoots @irthcomm
Analysts' Analyst retweeted
Reading the Leaves for the Future of WeedTech buff.ly/2vpNsL0 $MSRT #cannabis #smallcap @MassRoots @irthcomm
Analysts' Analyst retweeted
Hands-Free M300 Smart Glasses Picking Solution to John Deere buff.ly/2v4koXt $VUZI #smartglasses #smallcap @Vuzix @irthcomm
Analysts' Analyst retweeted
Hands-Free M300 Smart Glasses Picking Solution to John Deere buff.ly/2v4lPoI $VUZI #smartglasses #smallcap @Vuzix @irthcomm
Analysts' Analyst retweeted
Rosy futures predicted for global augmented and virtual reality markets buff.ly/2ueTa1K $VUZI #smallcap #VR #AR @Vuzix @irthcomm
$VUZI: The Clear Leader in Every Category buff.ly/2wwoOnU #smallcap @Vuzix @irthcomm @DanCarlson33 @TailwindsRsrch